Unlock instant, AI-driven research and patent intelligence for your innovation.

A dronedarone hydrochloride tablet and preparation method thereof

A technology of dronedarone hydrochloride tablet and dronedarone hydrochloride, applied in the field of dronedarone hydrochloride tablet and its preparation, surfactant-containing dronedarone hydrochloride tablet and its preparation, can solve the problem of Easy to stick, poor solubility and other problems, to achieve the effect of convenient operation, improved dissolution rate, and simple preparation process

Active Publication Date: 2021-01-29
SHANDONG NEWTIME PHARMA
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] In order to solve the problems of its poor solubility and easy sticking in the production process, the inventors have carried out a large number of experiments, and unexpectedly found that the melted skeleton material and poloxamer were melted and granulated by hot-melt extrusion technology, and then combined with After the drug is mixed, it is granulated and compressed, which can not only improve the solubility of the drug, but also solve the problem of easy sticking and punching during the production process of the preparation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A dronedarone hydrochloride tablet and preparation method thereof
  • A dronedarone hydrochloride tablet and preparation method thereof
  • A dronedarone hydrochloride tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030]

[0031] Preparation Process:

[0032] Copovidone and poloxamer are granulated using a hot-melt extruder, then mixed with dronedarone hydrochloride and cross-linked povidone evenly, and an appropriate amount of pure water is added to granulate, and the dried granules are added to the prescription amount of stearin Magnesium acid, mixed evenly, and compressed into tablets.

Embodiment 2

[0034]

[0035] Preparation Process:

[0036] Granulate acrylic resin E and poloxamer using a hot-melt extruder, then mix them evenly with dronedarone hydrochloride and cross-linked povidone, add an appropriate amount of pure water, granulate, and add the prescribed amount of stearin to the dried granules Magnesium acid, mixed evenly, and compressed into tablets.

Embodiment 3

[0038]

[0039] Preparation Process:

[0040] Granulate acrylic resin E and poloxamer using a hot-melt extruder, then mix them evenly with dronedarone hydrochloride and cross-linked povidone, add an appropriate amount of pure water, granulate, and add the prescribed amount of stearin to the dried granules Magnesium acid, mixed evenly, and compressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a dronedarone hydrochloride tablet containing a poloxamer surfactant and a preparation method thereof. The tablet comprises dronedarone hydrochloride, melting matrix material, poloxamer, disintegrant, lubricant; wherein, the melting matrix material is a pharmaceutically acceptable polymer material; the disintegrating agent is crospovidone, One or more of low-substituted hydroxypropyl cellulose, croscarmellose sodium, and sodium carboxymethyl starch; the lubricant is one or more of magnesium stearate, calcium stearate, and micropowder silica gel Several kinds. The preparation method comprises the following steps: first melting and granulating the poloxamer and molten skeleton material, and then mixing and granulating with dronedarone hydrochloride and other suitable auxiliary materials to form tablets. The technical solution of the present invention effectively overcomes the problem of easy sticking and punching during the preparation of dronedarone hydrochloride tablets containing poloxamer surfactants, improves the dissolution rate of dronedarone hydrochloride, and is simple and easy to operate , suitable for mass production.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a dronedarone hydrochloride tablet and a preparation method thereof, more specifically, to a surfactant-containing dronedarone hydrochloride tablet and a preparation method thereof. Background technique [0002] Dronedarone hydrochloride (dronedarone hydrochloride), the chemical name is 2-n-butyl-3-[4-(3-di-n-butyl-aminopropoxy)benzoyl]-5-methylsulfabenzoyl Furan hydrochloride, CAS: 141625-93-6, is a newly developed drug for the treatment of arrhythmia by Sanofi-Aventis. In 2009, it was approved by the US FDA and Europe for the treatment of paroxysmal or persistent atrial fibrillation. [0003] Dronedarone hydrochloride has very low solubility in aqueous media, especially its solubility is pH-dependent at room temperature, and has a maximum solubility in the range of pH 3 to 5, which is about 1-2mg / ml, and at pH about 6 The solubility becomes very low at pH 7, and the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/20A61K31/343A61K47/38A61K47/10A61K47/32A61P9/06
Inventor 赵志全郝贵周张庆森
Owner SHANDONG NEWTIME PHARMA